Literature DB >> 27010471

Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study.

E Gélisse1,2, M Neuville2, E de Montmollin3, L Bouadma2,4, B Mourvillier2, J F Timsit2,4, R Sonneville5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27010471     DOI： 10.1007/s00134-016-4267-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.

Authors:  Etienne de Montmollin; Lila Bouadma; Nathalie Gault; Bruno Mourvillier; Eric Mariotte; Sarah Chemam; Laurent Massias; Emmanuelle Papy; Florence Tubach; Michel Wolff; Romain Sonneville
Journal:  Intensive Care Med       Date:  2014-04-01       Impact factor: 17.440

2.  Amikacin dosing in the ICU: we now know more, but still not enough….

Authors:  Francesco G De Rosa; Jason A Roberts
Journal:  Intensive Care Med       Date:  2014-05-10       Impact factor: 17.440

3.  Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation.

Authors:  Matthieu Schmidt; Nicolas Bréchot; Sarah Hariri; Marguerite Guiguet; Charles Edouard Luyt; Ralouka Makri; Pascal Leprince; Jean-Louis Trouillet; Alain Pavie; Jean Chastre; Alain Combes
Journal:  Clin Infect Dis       Date:  2012-09-18       Impact factor: 9.079

4.  Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock.

Authors:  Fabio Silvio Taccone; Pierre-François Laterre; Herbert Spapen; Thierry Dugernier; Isabelle Delattre; Brice Layeux; Daniel De Backer; Xavier Wittebole; Pierre Wallemacq; Jean-Louis Vincent; Frédérique Jacobs
Journal:  Crit Care       Date:  2010-04-06       Impact factor: 9.097
  4 in total
  7 in total

Review 1.  Pharmacokinetic and Pharmacodynamic Considerations of Antibiotics of Last Resort in Treating Gram-Negative Infections in Adult Critically Ill Patients.

Authors:  Mojdeh S Heavner; Kimberly C Claeys; Anne M Masich; Jeffrey P Gonzales
Journal:  Curr Infect Dis Rep       Date:  2018-04-05       Impact factor: 3.725

Review 2.  [Clinical pharmacokinetics of anti-infective drugs in extracorporeal membrane oxygenation].

Authors:  A Reimer; H Vogl; S Schmid; S Gfrörer; M Bürle; M Hoffmann; G Geldner
Journal:  Anaesthesist       Date:  2019-12       Impact factor: 1.041

Review 3.  Medicating patients during extracorporeal membrane oxygenation: the evidence is building.

Authors:  Amy L Dzierba; Darryl Abrams; Daniel Brodie
Journal:  Crit Care       Date:  2017-03-21       Impact factor: 9.097

4.  Predictors of insufficient peak amikacin concentration in critically ill patients on extracorporeal membrane oxygenation.

Authors:  Cyril Touchard; Alexandra Aubry; Philippine Eloy; Nicolas Bréchot; Guillaume Lebreton; Guillaume Franchineau; Sebastien Besset; Guillaume Hékimian; Ania Nieszkowska; Pascal Leprince; Charles-Edouard Luyt; Alain Combes; Matthieu Schmidt
Journal:  Crit Care       Date:  2018-08-19       Impact factor: 9.097

5.  Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation.

Authors:  Claire Pressiat; Agathe Kudela; Quentin De Roux; Nihel Khoudour; Claire Alessandri; Hakim Haouache; Dominique Vodovar; Paul-Louis Woerther; Alice Hutin; Bijan Ghaleh; Anne Hulin; Nicolas Mongardon
Journal:  Pharmaceutics       Date:  2022-01-26       Impact factor: 6.321

6.  Pharmacokinetics of Commonly Used Antimicrobials in Critically Ill Adults During Extracorporeal Membrane Oxygenation: A Systematic Review.

Authors:  Gordan Samoukovic; David R Williamson; Marc-Alexandre Duceppe; Salmaan Kanji; Anh Thu Do; Ni Ruo; Yiorgos Alexandros Cavayas; Martin Albert; Maxime Robert-Halabi; Samara Zavalkoff; Patrice Dupont
Journal:  Drugs       Date:  2021-07-05       Impact factor: 9.546

Review 7.  [Effect of extracorporeal membrane oxygenation on pharmacokinetics of antimicrobial drugs: recent progress and recommendations].

Authors:  Y Zhang; Z Zeng; Q Zhang; Q Ou; Z Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.